CD38 in Neurodegeneration and Neuroinflammation
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are characterized by neuronal degeneration as well as neuroinflammation. While CD38 is strongly expressed in brain cells including neurons, astrocytes as well as microglial cells, the role played by CD38 in neurodegeneration and neuroinflammation remains elusive. Yet, CD38 expression increases as a consequence of aging which is otherwise the primary risk associated with neurodegenerative diseases, and several experimental data demonstrated that CD38 knockout mice are protected from neurodegenerative and neuroinflammatory insults. Moreover, nicotinamide adenine dinucleotide, whose levels are tightly controlled by CD38, is a recognized and potent neuroprotective agent, and NAD supplementation was found to be beneficial against neurodegenerative diseases. The aims of this review are to summarize the physiological role played by CD38 in the brain, present the arguments indicating the involvement of CD38 in neurodegeneration and neuroinflammation, and to discuss these observations in light of CD38 complex biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 2×
“However, aging is the primary risk factor associated with the vast majority of NDDs [4], and several data tend to indicate that CD38 expression increases in the brain as a consequence of aging.”
BackgroundHow neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · cited 1×
“Furthermore, non-cell-autonomous processes like neuroinflammation are also heavily suspected to participate in neurodegeneration [2].”
BackgroundTransfer of mitochondria from astrocytes to neurons after stroke
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., & Lo, E. H. (2016) · Nature · doi:10.1038/nature18928 · Cited by 1,423 · cited 2×
“CD38 is also involved in the transfer of mitochondria from astrocytes to neurons after stroke, thus linking CD38 to astrocyteinduced neuroprotection [49].”
BackgroundNAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 1×
“Moreover, senolytic treatments were found to be neuroprotective in murine models of Alzheimer’s disease [72,73].”
BackgroundZhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977
Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., & Aydin, S. (2008) · Physiological Reviews · doi:10.1152/physrev.00035.2007 · Cited by 862 · cited 3×
“However, CD38 biology is complex and not restricted to its NAD-degrading ability [12].”
BackgroundInfluentialNAD+ in Brain Aging and Neurodegenerative Disorders
Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790 · cited 2×
“Since NAD is a potent neuroprotective and anti-inflammatory agent [5], this constitutes a first indirect proof of CD38 involvement in neurodegeneration and neuroinflammation.”
BackgroundCD38 is critical for social behaviour by regulating oxytocin secretion
Jin, D., Liu, H.-X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., Shnayder, N. A., Yamada, K., Noda, M., Seike, T., et al. (2007) · Nature · doi:10.1038/nature05526 · Cited by 665 · cited 1×
“This reduction in cADPR levels in these brain areas led to a reduction of oxytocin and vasopressin release, explaining the observed defects in maternal nurturing and social behavior characteristics of CD38 KO mice [39].”
Background
Research works printed but not linked: 54
- Gan, 2018, Converging pathways in neurodegeneration, from genetics to mechanisms, Nat. Neurosci., 21, 1300, 10.1038/s41593-018-0237-7 · DOI · Paper page
- Mehta, 2017, Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015, Expert Opin. Investig. Drugs, 26, 735, 10.1080/13543784.2017.1323868 · DOI · Paper page
- Clement, 2018, The Plasma NAD + Metabolome Is Dysregulated in “Normal” Aging, Rejuvenation Res., 22, 121, 10.1089/rej.2018.2077 · DOI · Paper page
- Chini, 2009, CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions, Curr. Pharm. Des., 15, 57, 10.2174/138161209787185788 · DOI · Paper page
- Aarhus, 1995, ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP, J. Biol. Chem., 270, 30327, 10.1074/jbc.270.51.30327 · DOI · Paper page
- Deaglio, 1998, Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member, J. Immunol., 160, 395, 10.4049/jimmunol.160.1.395 · DOI · Paper page
- Horenstein, 1998, CD38 binding to human myeloid cells is mediated by mouse and human CD31, Biochem. J., 330, 1129, 10.1042/bj3301129 · DOI
- Newman, 2003, Signal Transduction Pathways Mediated by PECAM-1, Arterioscler. Thromb. Vasc. Biol., 23, 953, 10.1161/01.ATV.0000071347.69358.D9 · DOI · Paper page
- Kalinowska, 2006, PECAM-1, a key player in neuroinflammation, Eur. J. Neurol., 13, 1284, 10.1111/j.1468-1331.2006.01640.x · DOI · Paper page
- Fang, 2018, CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosome, J. Biol. Chem., 293, 8151, 10.1074/jbc.RA118.002113 · DOI
- Zubiaur, 2002, CD38 Is Associated with Lipid Rafts and upon Receptor Stimulation Leads to Akt/Protein Kinase B and Erk Activation in the Absence of the CD3-ζ Immune Receptor Tyrosine-based Activation Motifs, J. Biol. Chem., 277, 13, 10.1074/jbc.M107474200 · DOI
- Ceni, 2003, CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain, Biochem. J., 370, 175, 10.1042/bj20020604 · DOI · Paper page
- Yamada, 1997, Ultrastructural localization of CD38 immunoreactivity in rat brain, Brain Res., 756, 52, 10.1016/S0006-8993(97)00117-0 · DOI
- Braidy, 2014, Mapping NAD+ metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence, Biogerontology, 15, 177, 10.1007/s10522-013-9489-5 · DOI · Paper page
- Ma, 2014, CD38 plays key roles in both antioxidation and cell survival of H2O2-treated primary rodent astrocytes, Int. J. Physiol. Pathophysiol. Pharmacol., 6, 102
- Mamik, 2011, HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanisms, J. Neuroinflamm., 8, 145, 10.1186/1742-2094-8-145 · DOI
- Kou, 2009, CD38 regulation in activated astrocytes: Implications for neuroinflammation and HIV-1 brain infection, J. Neurosci. Res., 87, 2326, 10.1002/jnr.22060 · DOI · Paper page
- Verderio, 2001, Evidence of a role for cyclic ADP-ribose in calcium signalling and neurotransmitter release in cultured astrocytes, J. Neurochem., 78, 646, 10.1046/j.1471-4159.2001.00455.x · DOI · Paper page
- Ma, 2012, CD38 is a key enzyme for the survival of mouse microglial BV2 cells, Biochem. Biophys. Res. Commun., 418, 714, 10.1016/j.bbrc.2012.01.084 · DOI
- Ma, 2014, Basal CD38/cyclic ADP-ribose-dependent signaling mediates ATP release and survival of microglia by modulating connexin 43 hemichannels, Glia, 62, 943, 10.1002/glia.22651 · DOI · Paper page
- Mayo, 2008, Dual Role of CD38 in Microglial Activation and Activation-Induced Cell Death, J. Immunol., 181, 92, 10.4049/jimmunol.181.1.92 · DOI · Paper page
- Aksoy, 2006, Regulation of intracellular levels of NAD: A novel role for CD38, Biochem. Biophys. Res. Commun., 345, 1386, 10.1016/j.bbrc.2006.05.042 · DOI · Paper page
- Nelissen, 2018, CD38 is Required for Dendritic Organization in Visual Cortex and Hippocampus, Neuroscience, 372, 114, 10.1016/j.neuroscience.2017.12.050 · DOI
- Higashida, 2007, Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system, Neurochem. Int., 51, 192, 10.1016/j.neuint.2007.06.023 · DOI
- Ceni, 2003, Evidence for an Intracellular ADP-ribosyl Cyclase/NAD+-glycohydrolase in Brain from CD38-deficient Mice, J. Biol. Chem., 278, 40670, 10.1074/jbc.M301196200 · DOI · Paper page
- Soares, 2006, NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells, AJP Cell Physiol., 292, C227, 10.1152/ajpcell.00638.2005 · DOI · Paper page
- Martucci, 2019, A multiscale analysis in CD38 −/− mice unveils major prefrontal cortex dysfunctions, FASEB J., 33, 5823, 10.1096/fj.201800489R · DOI
- Lee, M.R., Shin, J.H., Deschaine, S., Daurio, A.M., Stangl, B.L., Yan, J., Ramchandani, V.A., Schwandt, M.L., Grodin, E.N., and Momenan, R. (2019). A role for the CD38 rs3796863 polymorphism in alcohol and monetary reward: evidence from CD38 knockout mice and alcohol self-administration, [11C]-raclopride binding, and functional MRI in humans. Am. J. Drug Alcohol Abuse, 1–13. · DOI
- Demeule, 2001, Isolation of endothelial cells from brain, lung, and kidney: Expression of the multidrug resistance p-glycoprotein isoforms, Biochem. Biophys. Res. Commun., 281, 827, 10.1006/bbrc.2001.4312 · DOI
- Lertkiatmongkol, 2016, Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31), Curr. Opin. Hematol., 23, 253, 10.1097/MOH.0000000000000239 · DOI · Paper page
- Ilan, 2001, PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics, FASEB J., 15, 362, 10.1096/fj.00-0372com · DOI · Paper page
- Goldberger, 1994, Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form, J. Biol. Chem., 269, 17183, 10.1016/S0021-9258(17)32538-3 · DOI
- Zaremba, 2002, sPECAM-1 in serum and CSF of acute ischaemic stroke patients, Acta Neurol. Scand., 106, 292, 10.1034/j.1600-0404.2002.01339.x · doi:10.1034/j.1600-0404.2002.01339.x
- Zaremba, 2002, Soluble platelet endothelial cell adhesion molecule-1 in ischaemic stroke patients is related to the extent of early brain damage, Cent. J. Immunol., 27, 90
- Banerjee, 2008, CD38/Cyclic ADP-Ribose Regulates Astrocyte Calcium Signaling: Implications for Neuroinflammation and HIV-1-Associated Dementia, J. Neuroimmune Pharmacol., 3, 154, 10.1007/s11481-008-9105-7 · DOI
- Levy, 2012, CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages, Neuro. Oncol., 14, 1037, 10.1093/neuonc/nos121 · DOI
- Blacher, 2015, Inhibition of glioma progression by a newly discovered CD38 inhibitor, Int. J. Cancer, 136, 1422, 10.1002/ijc.29095 · DOI · Paper page
- Wang, 2017, Blocking the CD38/cADPR pathway plays a double-edged role in LPS stimulated microglia, Neuroscience, 361, 34, 10.1016/j.neuroscience.2017.08.010 · DOI
- Wakade, C., Chong, R., Bradley, E., Thomas, B., and Morgan, J. (2014). Upregulation of GPR109A in Parkinson’s Disease. PLoS ONE, 9. · DOI · Paper page
- Wang, 2017, Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death, Cell Rep., 20, 2184, 10.1016/j.celrep.2017.08.022 · DOI
- Braidy, 2013, Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis, Brain Res., 1537, 267, 10.1016/j.brainres.2013.08.025 · DOI
- Otsuka, 1994, Immunoreactivity in Alzheimer’s neurofibrillary tangles (abstract), Brain Pathol., 4, 558
- Jude, 2012, miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells, Am. J. Physiol. Lung Cell. Mol. Physiol., 303, L460, 10.1152/ajplung.00041.2012 · DOI
- Dileepan, 2014, MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells, Respir. Res., 15, 107, 10.1186/s12931-014-0107-0 · DOI
- Saad, 2011, Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson’s disease in the European population, Hum. Mol. Genet., 20, 615, 10.1093/hmg/ddq497 · DOI · Paper page
- Choe, C., Lardong, K., Gelderblom, M., Ludewig, P., Leypoldt, F., Koch-Nolte, F., Gerloff, C., and Magnus, T. (2011). CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia. PLoS ONE, 6. · DOI
- Kim, 2016, Impaired learning and memory in CD38 null mutant mice, Mol. Brain, 9, 16, 10.1186/s13041-016-0195-5 · DOI · Paper page
- Herrmann, 2016, Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis, Dis. Model. Mech., 9, 1211
- Roboon, 2019, Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination, Front. Cell. Neurosci., 13, 258, 10.3389/fncel.2019.00258 · DOI · Paper page
- Turnquist, 2016, p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration, Cell Death Differ., 23, 1515, 10.1038/cdd.2016.37 · DOI · Paper page
- Covarrubias, A.J., Kale, A., Perrone, R., Lopez-Dominguez, J.A., Pisco, A.O., Kasler, H.G., Schmidt, M.S., Wiley, C.D., Iyer, S.S., and Basisty, N. (2019). Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages. bioRxiv, 609438. · doi:10.1101/609438
- Usmani, 2018, CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance, Front. Immunol., 9, 2134, 10.3389/fimmu.2018.02134 · DOI · Paper page
- Hogan, K.A., Chini, C.C.S., and Chini, E.N. (2019). The Multi-faceted Ecto-enzyme CD38: Roles in immunomodulation, cancer, aging, and metabolic diseases. Front. Immunol., 10. · DOI · Paper page
- Milo, 2019, Therapies for multiple sclerosis targeting B cells, Croat. Med. J., 60, 87, 10.3325/cmj.2019.60.87 · DOI
Cited by
CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
Piedra-Quintero, Z. L., Wilson, Z., Nava, P., & Guerau-de-Arellano, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.597959 · Cited by 332
Neuroinflammation in Alzheimer’s Disease
Onyango, I. G., Jauregui, G. V., Čarná, M., Bennett, J. P., & Stokin, G. B. (2021) · Biomedicines · doi:10.3390/biomedicines9050524 · Cited by 330
“CD38 is a NAD glycohydrolase that is expressed by neurons, astrocytes, and microglial cells and plays an important role in neuroinflammatory and brain repair processes [403].”
Backgroundde Klein, N., Tsai, E. A., Vochteloo, M., Baird, D., Huang, Y., Chen, C.-Y., van Dam, S., Oelen, R., Deelen, P., Bakker, O. B., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01300-6 · Cited by 272
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Rajesh, Y., & Kanneganti, T.-D. (2022) · Cells · doi:10.3390/cells11121885 · Cited by 262
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
Dräger, N. M., Sattler, S. M., Huang, C. T.-L., Teter, O. M., Leng, K., Hashemi, S. H., Hong, J., Aviles, G., Clelland, C. D., Zhan, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01131-4 · Cited by 258
The mitochondrial permeability transition: Nexus of aging, disease and longevity
Rottenberg, H., & Hoek, J. B. (2021) · Cells · doi:10.3390/cells10010079 · Cited by 94
“CD38 expression increases with age, which further enhances the destructive effects of mPTP opening in aging (92).”
BackgroundReactive Astrocytes and Emerging Roles in Central Nervous System (CNS) Disorders
Liddelow, S. A., Olsen, M. L., & Sofroniew, M. V. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041356 · Cited by 55
Metadata
- Authors
- Guerreiro, S., Privat, A.-L., Bressac, L., & Toulorge, D.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-02-18
- Volume
- 9
- Issue
- 2
- Pages
- 471
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3008840800
- Cited by
- 141
- References
- 24
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.